E
Arrowhead Pharmaceuticals, Inc. ARWR
$21.33 $0.582.80% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 72.45% 69.42% -115.53% -192.04% -197.41%
Total Depreciation and Amortization 29.48% 32.68% 39.10% 48.84% 54.32%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 27.62% 24.84% 11.95% 2.78% -4.02%
Change in Net Operating Assets -63.01% -34.06% 1,021.02% 148.68% 160.95%
Cash from Operations 106.21% 123.80% -150.38% -200.77% -78.73%
Capital Expenditure 78.21% 75.83% 61.10% 19.96% -24.42%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -2,767.47% -1,806.70% -228.07% -445.74% -73.89%
Cash from Investing -154.94% -204.79% -926.28% -336.87% -84.71%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -43.30% -43.36% 15,644.21% 14,038.68% 13,902.33%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -66.27% -- -- -81.25% -80.00%
Cash from Financing -4.73% 27.60% 32,366.73% 244.01% 90.55%
Foreign Exchange rate Adjustments 28,178.57% 2,205.70% 6,918.97% 3,540.16% 105.15%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 268.06% 899.52% 97.00% -384.34% -5.37%